Masashi Mukoyama

Q: What Schools Are Affiliated With Masashi Mukoyama

Masashi Mukoyama is affiliated with the following schools: University of Alabama, Kumamoto University, Kyoto University

Masashi Mukoyama's AcademicInfluence.com Rankings

Masashi Mukoyama

Economics

#3573

World Rank

#4046

Historical Rank

Macroeconomics

#328

World Rank

#347

Historical Rank

economics Degrees

Download Badge

Economics

Masashi Mukoyama's Degrees

PhD Economics University of Tokyo
Masters Economics University of Tokyo
Bachelors Economics University of Tokyo

Similar Degrees You Can Earn

Why Is Masashi Mukoyama Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Masashi Mukoyama's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Localization and Mechanism of Secretion of B‐Type Natriuretic Peptide in Comparison With Those of A‐Type Natriuretic Peptide in Normal Subjects and Patients With Heart Failure (1994) (1386)
Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. (1991) (1369)
Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. (2005) (890)
The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019) (2019) (776)
Expression cloning of type 2 angiotensin II receptor reveals a unique class of seven-transmembrane receptors (1995) (764)
Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide. (1992) (750)
Different Secretion Patterns of Atrial Natriuretic Peptide and Brain Natriuretic Peptide in Patients With Congestive Heart Failure (1993) (625)
Increased Plasma Levels of Brain Natriuretic Peptide in Patients With Acute Myocardial Infarction (1993) (616)
Cardiac fibrosis in mice lacking brain natriuretic peptide. (2000) (608)
Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II. (1993) (507)
Hemodynamic, Renal, and Hormonal Responses to Brain Natriuretic Peptide Infusion in Patients With Congestive Heart Failure (1991) (458)
Increased plasma endothelin level in patients with essential hypertension. (1990) (377)
Kidney produces a novel acylated peptide, ghrelin (2000) (349)
Increased human brain natriuretic peptide in congestive heart failure. (1990) (300)
C-type natriuretic peptide (CNP) in rats and humans. (1991) (300)
Brain natriuretic peptide is a novel cardiac hormone. (1989) (290)
Natriuretic peptides as cardiac hormones in normotensive and spontaneously hypertensive rats. The ventricle is a major site of synthesis and secretion of brain natriuretic peptide. (1991) (286)
Plasma ghrelin and desacyl ghrelin concentrations in renal failure. (2002) (273)
Cloning and expression of human endothelin‐1 receptor cDNA (1991) (271)
Expression of Brain Natriuretic Peptide Gene in Human Heart: Production in the Ventricle (1991) (271)
Reduction in connective tissue growth factor by antisense treatment ameliorates renal tubulointerstitial fibrosis. (2004) (247)
Isolation and sequence determination of human brain natriuretic peptide in human atrium (1990) (243)
Ventricular Expression of Brain Natriuretic Peptide in Hypertrophic Cardiomyopathy (1993) (227)
Urinary neutrophil gelatinase-associated lipocalin levels reflect damage to glomeruli, proximal tubules, and distal nephrons. (2009) (206)
Human brain natriuretic peptide, a novel cardiac hormone (1990) (185)
Role of connective tissue growth factor in fibronectin expression and tubulointerstitial fibrosis. (2002) (172)
Role of p38 mitogen-activated protein kinase activation in podocyte injury and proteinuria in experimental nephrotic syndrome. (2005) (166)
Human Induced Pluripotent Stem Cell-Derived Podocytes Mature into Vascularized Glomeruli upon Experimental Transplantation. (2016) (165)
Role of connective tissue growth factor in profibrotic action of transforming growth factor-beta: a potential target for preventing renal fibrosis. (2001) (152)
Overexpression of connective tissue growth factor in podocytes worsens diabetic nephropathy in mice. (2008) (137)
Acute pulmonary alveolar hypoxia increases lung and plasma endothelin-1 levels in conscious rats. (1991) (136)
Cloning of cDNA and analysis of the gene for mouse angiotensin II type 2 receptor. (1993) (132)
Rat brain natriuretic peptide--tissue distribution and molecular form. (1990) (132)
Isolation and Characterization of CA XIV, a Novel Membrane-bound Carbonic Anhydrase from Mouse Kidney* (1999) (130)
Augmented Expression of Atrial Natriuretic Polypeptide Gene in Ventricles of Spontaneously Hypertensive Rats (SHR) and SHR‐Stroke Prone (1988) (130)
Augmented secretion of brain natriuretic peptide in acute myocardial infarction. (1991) (128)
Phenotype-related alteration in expression of natriuretic peptide receptors in aortic smooth muscle cells. (1992) (121)
Rat receptor-activity-modifying proteins (RAMPs) for adrenomedullin/CGRP receptor: cloning and upregulation in obstructive nephropathy. (2000) (118)
Prevention of diabetic nephropathy in rats by prostaglandin E receptor EP1-selective antagonist. (2002) (117)
Synthesis of atrial natriuretic polypeptide in human failing hearts. Evidence for altered processing of atrial natriuretic polypeptide precursor and augmented synthesis of beta-human ANP. (1988) (105)
Altered Gene Expression Related to Glomerulogenesis and Podocyte Structure in Early Diabetic Nephropathy of db/db Mice and Its Restoration by Pioglitazone (2006) (98)
Exacerbation of diabetic nephropathy by hyperlipidaemia is mediated by Toll-like receptor 4 in mice (2012) (97)
Molecular biology of angiotensin receptors: target for drug research? (1994) (94)
Biosynthesis, secretion, and receptor selectivity of human brain natriuretic peptide. (1991) (90)
Crucial Role of Mesangial Cell-derived Connective Tissue Growth Factor in a Mouse Model of Anti-Glomerular Basement Membrane Glomerulonephritis (2017) (89)
Autocrine/paracrine role of adrenomedullin in cultured endothelial and mesangial cells. (1998) (89)
MicroRNA-26a inhibits TGF-β-induced extracellular matrix protein expression in podocytes by targeting CTGF and is downregulated in diabetic nephropathy (2015) (88)
γ-Atrial natriuretic polypeptide (γANP)-derived peptides in human plasma: Cosecretion of N-terminal γANP fragment and αANP (1988) (84)
Growth-dependent induction of angiotensin II type 2 receptor in rat mesangial cells. (1997) (82)
The prostaglandin E2 and F2 alpha receptor genes are expressed in human myometrium and are down-regulated during pregnancy. (1997) (81)
Kidney‐specific expression of a novel mouse organic cation transporter‐like protein (1997) (79)
Chronically elevated plasma C-type natriuretic peptide level stimulates skeletal growth in transgenic mice. (2009) (79)
Expression and Distribution of Atrial Natriuretic Peptide in Human Hypertrophic Ventricle of Hypertensive Hearts and Hearts With Hypertrophic Cardiomyopathy (1991) (76)
The neuroprotective and vasculo-neuro-regenerative roles of adrenomedullin in ischemic brain and its therapeutic potential. (2006) (75)
Atrial natriuretic polypeptide (ANP) in human ventricle. Increased gene expression of ANP in dilated cardiomyopathy. (1987) (70)
CTGF in kidney fibrosis and glomerulonephritis (2018) (69)
Endothelin in human plasma and culture medium of aortic endothelial cells--detection and characterization with radioimmunoassay using monoclonal antibody. (1989) (68)
The Growth-dependent Expression of Angiotensin II Type 2 Receptor Is Regulated by Transcription Factors Interferon Regulatory Factor-1 and −2 (*) (1995) (68)
Therapeutic Impact of Leptin on Diabetes, Diabetic Complications, and Longevity in Insulin-Deficient Diabetic Mice (2011) (67)
Disruption of klotho gene causes an abnormal energy homeostasis in mice. (2000) (66)
Plasma concentration of atrial natriuretic peptide and brain natriuretic peptide during normal human pregnancy and the postpartum period. (1994) (65)
Role of Prostaglandin E Receptor EP1 Subtype in the Development of Renal Injury in Genetically Hypertensive Rats (2003) (65)
Ameliorated glomerular injury in mice overexpressing brain natriuretic peptide with renal ablation. (2000) (64)
Ventricular expression of atrial and brain natriuretic peptides in dilated cardiomyopathy. An immunohistocytochemical study of the endomyocardial biopsy specimens using specific monoclonal antibodies. (1993) (64)
Isolation and sequence determination of rat cardiac natriuretic peptide. (1989) (62)
Overexpression of brain natriuretic peptide in mice ameliorates immune-mediated renal injury. (2001) (60)
CTGF Mediates Tumor-Stroma Interactions between Hepatoma Cells and Hepatic Stellate Cells to Accelerate HCC Progression. (2018) (59)
Angiotensin converting enzyme and genetic hypertension: cloning of rat cDNAs and characterization of the enzyme. (1994) (59)
Application of Monoclonal Antibodies for Endothelin to Hypertensive Research (1990) (59)
Chronic blockade of endogenous atrial natriuretic polypeptide (ANP) by monoclonal antibody against ANP accelerates the development of hypertension in spontaneously hypertensive and deoxycorticosterone acetate-salt-hypertensive rats. (1989) (58)
C-type natriuretic peptide in chronic renal failure and its action in humans. (1996) (58)
Radioimmunoassay for brain natriuretic peptide (BNP) detection of BNP in canine brain. (1989) (57)
Characterization of Natriuretic Peptide Receptors in Cultured Cells (1992) (57)
Ventricular expression of atrial natriuretic polypeptide and its relations with hemodynamics and histology in dilated human hearts. Immunohistochemical study of the endomyocardial biopsy specimens. (1989) (54)
Connective Tissue Growth Factor Participates in Scar Formation of Crescentic Glomerulonephritis (2003) (54)
Redistribution of connexin43 expression in glomerular podocytes predicts poor renal prognosis in patients with type 2 diabetes and overt nephropathy. (2006) (54)
Roles of prostaglandin E receptors in mesangial cells under high-glucose conditions. (1999) (53)
Manipulation of Nephron-Patterning Signals Enables Selective Induction of Podocytes from Human Pluripotent Stem Cells. (2019) (53)
Prevention and reversal of renal injury by leptin in a new mouse model of diabetic nephropathy (2005) (52)
Atrial natriuretic polypeptide in brain--implication of central cardiovascular control. (1986) (52)
Pleiotrophin triggers inflammation and increased peritoneal permeability leading to peritoneal fibrosis. (2012) (51)
Molecular cloning and expression of a novel klotho-related protein (2000) (51)
Angiopoietin-like protein 2 increases renal fibrosis by accelerating transforming growth factor-β signaling in chronic kidney disease. (2016) (47)
Increase of Total Nephron Albumin Filtration and Reabsorption in Diabetic Nephropathy. (2017) (46)
Rat Brain Natriuretic Peptide: Isolation From Rat Heart and Tissue Distribution (1990) (44)
Natriuretic peptide receptor guanylyl cyclase-A protects podocytes from aldosterone-induced glomerular injury. (2012) (44)
Plasma Brain Natriuretic Peptide Level in Pregnant Women With Pregnancy-Induced Hypertension (1993) (43)
Atrial natriuretic peptide in acute hypoxia-induced pulmonary hypertension in rats. (1991) (43)
Sirtuin 7 Deficiency Ameliorates Cisplatin-induced Acute Kidney Injury Through Regulation of the Inflammatory Response (2018) (42)
Endothelin in patients with chronic renal failure. (1991) (42)
Occurrence of a novel cardiac natriuretic peptide in rats. (1989) (42)
Atrial natriuretic polypeptide in spinal cord and autonomic ganglia. (1987) (42)
Detection and characterization of endothelin-1-like immunoreactivity in rat plasma. (1989) (41)
Association of circulating ANGPTL 3, 4, and 8 levels with medical status in a population undergoing routine medical checkups: A cross-sectional study (2018) (41)
Brain natriuretic peptide is present in the human amniotic fluid and is secreted from amnion cells. (1993) (41)
Type 2 angiotensin II receptor is expressed in human myometrium and uterine leiomyoma and is down-regulated during pregnancy. (1996) (40)
Circulating osteocrin stimulates bone growth by limiting C-type natriuretic peptide clearance (2017) (40)
Transgenic overexpression of brain natriuretic peptide prevents the progression of diabetic nephropathy in mice (2006) (40)
Coordinate regulation of endothelin and adrenomedullin secretion by oxidative stress in endothelial cells. (2001) (40)
Roles of connective tissue growth factor and prostanoids in early streptozotocin-induced diabetic rat kidney: the effect of aspirin treatment (2003) (39)
Reduction of Tubular Flow Rate as a Mechanism of Oliguria in the Early Phase of Endotoxemia Revealed by Intravital Imaging. (2015) (39)
Expression and role of angiotensin II type 2 receptor in the kidney and mesangial cells of spontaneously hypertensive rats. (2002) (38)
Modulatory role of vasopressin in secretion of atrial natriuretic polypeptide in conscious rats. (1987) (37)
Appearance of atrial natriuretic peptide in the ventricles in patients with myocardial infarction. (1990) (36)
Secretion of N-terminal fragment of gamma-human atrial natriuretic polypeptide. (1988) (35)
Brain natriuretic peptide levels in the umbilical venous plasma are elevated in fetal distress. (1993) (35)
Specific blockade of basic fibroblast growth factor gene expression in endothelial cells by antisense oligonucleotide. (1992) (35)
Characterization of a rat type 2 angiotensin II receptor stably expressed in 293 cells (1995) (34)
Angiogenic protein Cyr61 is expressed by podocytes in anti-Thy-1 glomerulonephritis. (2003) (33)
Regulation of stanniocalcin 1 and 2 expression in the kidney by klotho gene. (2003) (32)
Simultaneous measurement of atrial natriuretic polypeptide (ANP) messenger RNA and ANP in rat heart--evidence for a preferentially increased synthesis and secretion of ANP in left atrium of spontaneously hypertensive rats (SHR). (1987) (30)
Expression of CCN1 (CYR61) in developing, normal, and diseased human kidney. (2007) (29)
Effects of naloxone on vasopressin secretion in conscious rats: evidence for inhibitory role of endogenous opioid peptides in vasopressin secretion. (1989) (28)
Immunoradiometric assay for the N-terminal fragment of proatrial natriuretic peptide in human plasma. (1998) (28)
A Monoclonal Antibody to α‐Human Atrial Natriuretic Polypeptide (1988) (28)
Identification and distribution of atrial natriuretic polypeptide in ventricular myocardium of humans with myocardial infarction (1990) (26)
Obesity-promoting and anti-thermogenic effects of neutrophil gelatinase-associated lipocalin in mice (2017) (26)
[Natriuretic peptide family]. (2000) (26)
Effects of renal denervation on blood pressures in patients with hypertension: a systematic review and meta-analysis of randomized sham-controlled trials (2021) (25)
Increased Bone Turnover and Possible Accelerated Fracture Healing in a Murine Model With an Increased Circulating C-Type Natriuretic Peptide. (2015) (25)
An AKI biomarker lipocalin 2 in the blood derives from the kidney in renal injury but from neutrophils in normal and infected conditions (2015) (25)
Secretory form of atrial natriuretic polypeptide as cardiac hormone in humans and rats. (1987) (25)
Atrial Natriuretic Factor in Essential Hypertension and Adrenal Disorders (1988) (25)
A monoclonal antibody against N-terminus of α-atrial natriuretic polypeptide (α-ANP): A useful tool for preferential detection of naturally circulating ANP (1988) (25)
Identification of a novel R642C mutation in Na/Cl cotransporter with Gitelman's syndrome. (1999) (24)
Deletion of connective tissue growth factor ameliorates peritoneal fibrosis by inhibiting angiogenesis and inflammation (2018) (24)
Japanese-Western consensus meeting on biomarkers. (2011) (23)
Adrenomedullin inhibits connective tissue growth factor expression, extracellular signal-regulated kinase activation and renal fibrosis. (2008) (22)
Translational research of novel hormones: lessons from animal models and rare human diseases for common human diseases (2009) (22)
Impaired guanosine 3',5'-cyclic phosphate production in severe pregnancy-induced hypertension with high plasma levels of atrial and brain natriuretic peptides. (1997) (22)
Conversion of β-human atrial natriuretic polypeptide into α-human atrial natriuretic polypeptide in human plasma in vitro (1987) (22)
Gamma-atrial natriuretic polypeptide (gamma ANP)-derived peptides in human plasma: cosecretion of N-terminal gamma ANP fragment and alpha ANP. (1988) (21)
Atrial Natriuretic Polypeptide in Bovine Adrenal Medulla (1988) (21)
A protease-activated receptor-1 antagonist protects against podocyte injury in a mouse model of nephropathy. (2017) (21)
Chemotherapy in cancer patients undergoing haemodialysis: a nationwide study in Japan (2018) (20)
Macrophage-mediated glucolipotoxicity via myeloid-related protein 8/toll-like receptor 4 signaling in diabetic nephropathy (2013) (20)
Role of adrenomedullin and its receptor system in renal pathophysiology (2001) (20)
Distinct characteristics and outcomes in elderly-onset IgA vasculitis (Henoch-Schönlein purpura) with nephritis: Nationwide cohort study of data from the Japan Renal Biopsy Registry (J-RBR) (2018) (20)
Exaggerated secretion of atrial natriuretic polypeptide during dynamic exercise in patients with essential hypertension. (1988) (19)
Enzyme immunoassay for α-human atrial natriuretic polypeptide - direct measurement of plasma level (1988) (19)
Brain Renin‐Angiotensin Central Control of Secretion of Atrial Natriuretic Factor from the Heart (1988) (19)
Adrenomedullin-RAMP2 System Suppresses ER Stress-Induced Tubule Cell Death and Is Involved in Kidney Protection (2014) (19)
Inhibitory action of leumorphin on vasopressin secretion in conscious rats. (1988) (19)
O‐linked &bgr;‐N‐acetylglucosamine modification of proteins is essential for foot process maturation and survival in podocytes (2017) (18)
Circulating C-type natriuretic peptide (CNP) rescues chondrodysplastic CNP knockout mice from their impaired skeletal growth and early death. (2010) (18)
Effects of Intravenously Administered β‐Human Atrial Natriuretic Polypeptide in Humans (1988) (17)
Natriuretic peptide receptor guanylyl cyclase-A pathway counteracts glomerular injury evoked by aldosterone through p38 mitogen-activated protein kinase inhibition (2017) (16)
The Serine Protease Inhibitor Camostat Mesilate Attenuates the Progression of Chronic Kidney Disease through its Antioxidant Effects (2015) (16)
Podocyte-specific expression of tamoxifen-inducible Cre recombinase in mice. (2010) (15)
Ablation of the N-type calcium channel ameliorates diabetic nephropathy with improved glycemic control and reduced blood pressure (2016) (15)
Doxycycline attenuates cisplatin-induced acute kidney injury through pleiotropic effects. (2018) (15)
Low doses of endothelin-1 inhibit atrial natriuretic peptide secretion. (1993) (15)
Do statins play a role in renoprotection? (2014) (14)
PPAR-α transcriptional activity is required to combat doxorubicin-induced podocyte injury in mice. (2011) (13)
Vaccine targeting ANGPTL3 ameliorates dyslipidemia and associated diseases in mouse models of obese dyslipidemia and familial hypercholesterolemia (2021) (13)
Direct measurement of α‐human atrial natriuretic polypeptide in plasma by sensitive enzyme immunoassay (1988) (13)
Peritoneal Fibrosis and High Transport Are Induced in Mildly Pre-injured Peritoneum by 3,4-Dideoxyglucosone-3-ene in Mice (2013) (13)
Low Serum Neutrophil Gelatinase-associated Lipocalin Level as a Marker of Malnutrition in Maintenance Hemodialysis Patients (2015) (13)
Expression and distribution of atrial natriuretic polypeptide in the ventricles of children with myocarditis and/or myocardial infarction secondary to Kawasaki disease: immunohistochemical study. (1990) (13)
Secretion of N‐Terminal Fragment of γ‐Human Atrial Natriuretic Polypeptide (1988) (12)
Augmented synthesis of beta-human atrial natriuretic polypeptide in human failing hearts. (1988) (12)
Opioid modulation of vasopressin secretion in conscious rats. (1988) (11)
Protective role of podocyte autophagy against glomerular endothelial dysfunction in diabetes. (2020) (11)
PREPARATION OF A MONOCLONAL ANTIBODY AGAINST MOUSE BRAIN NATRIURETIC PEPTIDE (BNP) AND TISSUE DISTRIBUTION OF BNP IN MICE (1995) (11)
Liddle’s-like syndrome associated with nephrotic syndrome secondary to membranous nephropathy: the first case report (2018) (11)
Combination therapy with renin-angiotensin-aldosterone system inhibitor telmisartan and serine protease inhibitor camostat mesilate provides further renoprotection in a rat chronic kidney disease model. (2016) (11)
MAGI-2 orchestrates the localization of backbone proteins in the slit diaphragm of podocytes. (2020) (11)
Predictive Significance of Kidney Myeloid-Related Protein 8 Expression in Patients with Obesity- or Type 2 Diabetes-Associated Kidney Diseases (2014) (10)
Erythropoietin production by the kidney and the liver in response to severe hypoxia evaluated by Western blotting with deglycosylation (2020) (10)
Altered growth response to prostaglandin E2 and its receptor signaling in mesangial cells from stroke-prone spontaneously hypertensive rats (2001) (10)
Expression of prostaglandin E receptor EP4 subtype in rat adrenal zona glomerulosa: involvement in aldosterone release. (2000) (10)
Reduction in urinary excretion of neutrophil gelatinase-associated lipocalin by angiotensin receptor blockers in hypertensive patients (2009) (10)
Guanylyl Cyclase A in Both Renal Proximal Tubular and Vascular Endothelial Cells Protects the Kidney against Acute Injury in Rodent Experimental Endotoxemia Models (2018) (9)
Immunohistochemical localization of atrial natriuretic polypeptide (ANP) in human atrial and ventricular myocardiocytes (2004) (9)
Edoxaban Exerts Antioxidant Effects Through FXa Inhibition and Direct Radical-Scavenging Activity (2019) (8)
Pembrolizumab-associated thrombotic microangiopathy in a patient with urothelial cancer: a case report and literature review (2020) (8)
Central interaction of the brain atrial natriuretic polypeptide (ANP) system and the brain renin-angiotensin system in ANP secretion from heart--evidence for possible brain-heart axis. (1988) (8)
Cosecretion of peptides derived from gamma‐human atrial natriuretic polypeptide in normal volunteers and patients with essential hypertension and adrenal disorders (1988) (8)
Circulating angiopoietin-like protein 2 levels and mortality risk in patients receiving maintenance hemodialysis: a prospective cohort study. (2019) (8)
A serine protease inhibitor attenuates aldosterone-induced kidney injuries via the suppression of plasmin activity. (2016) (8)
Pharmacokinetics of brain natriuretic peptide in rats. (1992) (7)
Mild systemic thermal therapy ameliorates renal dysfunction in a rodent model of chronic kidney disease. (2016) (7)
Peptide affinity analysis of proteins that bind to an unstructured NH2-terminal region of the osmoprotective transcription factor NFAT5. (2016) (7)
Umbilical venous guanosine 3',5'-cyclic phosphate (cGMP) concentration increases in asphyxiated newborns. (1995) (7)
Statement of the Asian Hypertension Society Network: the Okinawa Declaration on the unity of hypertension societies in Asian countries and regions to overcome hypertension and hypertension-related diseases (2021) (7)
Fludrocortisone stimulates erythropoietin production in the intercalated cells of the collecting ducts. (2018) (7)
Immunohistochemical localization and semi-quantification of atrial natriuretic polypeptide (ANP) in formalin-fixed-paraffin-embedded normal human hearts--comparative study with radioimmunoassay. (1989) (7)
Expression of three isoforms of Na-K-2Cl cotransporter (NKCC2) in the kidney and regulation by dehydration. (2014) (7)
Dysregulation of PI3K and hippo signaling pathways synergistically induces chronic pancreatitis via Ctgf upregulation. (2021) (7)
Central actions of atrial natriuretic polypeptides in spontaneously hypertensive and normotensive rats. (1987) (7)
Optimal blood pressure target to prevent severe hypertension in pregnancy: A systematic review and meta-analysis (2022) (7)
Suppressed ER‐associated degradation by intraglomerular cross talk between mesangial cells and podocytes causes podocyte injury in diabetic kidney disease (2020) (6)
ALTERED GENE EXPRESSION OF NATRIURETIC PEPTIDE RECEPTOR SUBTYPES IN THE KIDNEY OF STROKE‐PRONE SPONTANEOUSLY HYPERTENSIVE RATS (1995) (6)
Analysis of Pathological Activities of CCN Proteins in Fibrotic Diseases: Kidney Fibrosis. (2017) (6)
Pathophysiological role of augmented atrial natriuretic polypeptide gene expression in DOCA-salt hypertension. Effects of atrial natriuretic polypeptide monoclonal antibody. (1991) (6)
Peptides derived from atrial natriuretic polypeptide precursor in human and monkey brains (1988) (5)
Inhibition of mitochondrial fission protects podocytes from albumin-induced cell damage in diabetic kidney disease. (2022) (5)
Roles of matricellular CCN2 deposited by osteocytes in osteoclastogenesis and osteoblast differentiation (2019) (5)
Usefulness of the quantitative measurement of urine protein at a community-based health checkup: a cross-sectional study (2020) (5)
Effects of Angiotensin II on Erythropoietin Production in the Kidney and Liver (2021) (5)
Preparation of monoclonal antibodies against atrial natriuretic polypeptide precursor and application to highly sensitive sandwich enzyme immunoassay (1988) (5)
Ablation of Myeloid Cell MRP8 Ameliorates Nephrotoxic Serum-induced Glomerulonephritis by Affecting Macrophage Characterization through Intraglomerular Crosstalk (2020) (4)
Role of renin-angiotensin system blockade in advanced CKD: to use or not to use? (2022) (4)
Post-translational processing and secretory pathway of human atriopeptin in rat pheochromocytoma cells. (1991) (4)
COVID-19 pandemic and hypertension: an updated report from the Japanese Society of Hypertension project team on COVID-19 (2022) (4)
Implication of Leumorphin in Inhibitory Control of Vasopressin Secretion in Conscious Rats (1988) (4)
3. Iron Metabolism in Pathogenic Bacteria and Biological Defense Mechanisms. (2010) (4)
Low-density lipoprotein apheresis for proteinuria in lupus nephritis with intraglomerular foam cells containing cholesterol crystals. (2015) (4)
Endothelin in human cerebrospinal fluid (1990) (3)
Clinical and histological features in pediatric and adolescent/young adult patients with renal disease: a cross-sectional analysis of the Japan Renal Biopsy Registry (J-RBR) (2021) (3)
TSS-Seq analysis of low pH-induced gene expression in intercalated cells in the renal collecting duct (2017) (3)
Conversion of beta-human atrial natriuretic polypeptide into alpha-human atrial natriuretic polypeptide in human plasma in vitro. (1987) (3)
Hormones of the Kidney (2005) (3)
Differentiation of endogenous erythropoietin and exogenous ESAs by Western blotting (2020) (3)
Reduction of sodium intake by intracerebroventricular injection of brain natriuretic peptide (BNP) in salt-depleted rats (1989) (3)
Preparation of monoclonal antibodies against brain natriuretic peptide and their application to radioimmunoassay and passive immunization. (1990) (3)
Potent Depressor Action of Leumorphin, a κ-Opioid Agonist, in Conscious Rats (1988) (3)
Special Japanese-Western Consensus Meeting on Biomarkers Executive Summary (2011) (3)
Impact of left ventricular hypertrophy on the time-course of renal function in hypertensive patients – a subanalysis of the CASE-J trial –. (2010) (3)
Circulating angiopoietin-like protein 2 levels and arterial stiffness in patients receiving maintenance hemodialysis: A cross-sectional study. (2020) (3)
Searching for novel intercellular signal-transducing molecules in the kidney and their clinical application (2010) (3)
Efficacy of continuous erythropoietin receptor activator for end-stage renal disease patients with renal anemia before and after peritoneal dialysis initiation (2020) (3)
Renal angioplasty for atherosclerotic renal artery stenosis revisited – efficacy and safety of renal artery stenting in the J-RAS study. (2015) (3)
Successful treatment of rapidly progressive Immunoglobulin A nephropathy with human immunodeficiency virus infection by steroid pulse therapy and tonsillectomy (2016) (2)
Expression of atrial natriuretic factor gene in hearts from neonates of spontaneously hypertensive rats and stroke‐prone spontaneously hypertensive rats (1988) (2)
Long COVID and hypertension-related disorders: a report from the Japanese Society of Hypertension Project Team on COVID-19 (2022) (2)
t6A and ms2t6A Modified Nucleosides in Serum and Urine as Strong Candidate Biomarkers of COVID-19 Infection and Severity (2022) (2)
Successful full-term delivery in a patient with maintenance hemodialysis using natriuretic peptides as volume markers without X-ray examination: a case report and literature review (2019) (2)
Monoclonal antibody against brain natriuretic peptide and characterization of brain natriuretic peptide-transgenic mice (2001) (2)
Renal tubular acidosis complicated with hyponatremia due to cortisol insufficiency (2015) (2)
[Adrenomedullin receptors]. (1998) (2)
Osteocrin, a bone-derived humoral factor, exerts a renoprotective role in ischemia–reperfusion injury in mice (2021) (2)
Possible antagonistic relationship between atrial natriuretic peptide (ANP)-brain natriuretic peptide (BNP) system and brain renin-angiotensin system in central control of body fluid and cardiovascular function. (1988) (2)
Multicentre Study on the Efficacy of Brachial Artery Transposition Among Haemodialysis Patients. (2021) (2)
A serine protease inhibitor camostat mesilate prevents podocyte apoptosis and attenuates podocyte injury in metabolic syndrome model rats. (2021) (2)
Sensitive Chemiluminescent Enzyme Immunoassay for Determination of Endothelin-1 (1996) (1)
Mineralocorticoid receptor blockers for moderate kidney dysfunction: more merit than ever? (2021) (1)
Refractory peritonitis by spontaneous perforation of the common bile duct in a patient receiving peritoneal dialysis (2017) (1)
Effects of Roxadustat on Erythropoietin Production in the Rat Body (2022) (1)
Erratum: Plasma ghrelin and desacyl ghrelin concentrations in renal failure (Journal of the American Society of Nephrology (November 2002) 13 (2748-2752)) (2003) (1)
[Systemic AA amyloidosis caused by familial Mediterranean fever and response to colchicine]. (2008) (1)
Long-term Effectiveness of a Primary Care Practice Facilitation Program for Chronic Kidney Disease Management: An Extended Follow-up of a Cluster-Randomized FROM-J Study. (2022) (1)
Hyperglycemia and Thrombocytopenia　― Combinatorially Increase the Risk of Mortality in Patients With Acute Myocardial Infarction Undergoing Veno-Arterial Extracorporeal Membrane Oxygenation ― (2021) (1)
[A family of natriuretic peptides (ANP.BNP)]. (1989) (1)
PS-BPR02-2: ECULIZUMAB FOR RESCUE OF THROMBOTIC MICROANGIOPATHY IN MALIGNANT HYPERTENSION ASSOCIATED WITH MCTD (2023) (1)
-416- EFFECTS OF BAY K 8644, A VOLTAGE-SENSITIVE CALCIUM CHANNEL AGONIST, ON SECRETION OF ATRIAL NATRIURETIC POLYPEPTIDE FROM ISOLATED RAT HEARTS (1987) (1)
Atrial natriuretic peptide in the ventricles of patients with dilated cardiomyopathy and human foetuses (1989) (1)
Pharmacokinetics of liposomal amphotericin B during hemodialysis using polysulfone/high-flux membrane (2015) (1)
Regression of hepatitis C virus‐associated membranoproliferative glomerulonephritis with direct‐acting antiviral therapy after liver transplantation (2019) (1)
Production and Analysis of Conditional KO Mice of CCN2 in Kidney. (2017) (1)
[Novel biological involvements of siderophore-binding proteins in hematopoiesis, cell differentiation, tissue injury, carcinogenesis and infections]. (2009) (1)
A nationwide analysis of renal and patient outcomes for adults with lupus nephritis in Japan (2022) (1)
Transthyretin‐related familial amyloidotic polyneuropathy found with abnormal urinalysis at a general health checkup (2016) (1)
Prognostic Nutritional Index as a Predictor of Mortality in 101,616 Patients Undergoing Hemodialysis (2023) (1)
Insufficiency of urinary acid excretion of overweight or obese patients with chronic kidney disease and its involvement with renal tubular injury (2019) (1)
[Disease biomarkers for CKD]. (2012) (1)
Brain Natriuretic Peptide is a Novel Cardiac Hormone Secreted from the Ventricle in Humans (1991) (1)
Regulation of Rhcg, an ammonia transporter, by aldosterone in the kidney. (2021) (1)
[Expression of atrial natriuretic polypeptide in ventricles of heart with hypertrophic cardiomyopathy: an immunohistochemical study of endomyocardial specimens]. (1991) (1)
Atrial natriuretic polypeptide in the brain: implication of central cardiovascular control. (1986) (1)
The serine protease plasmin plays detrimental roles in epithelial sodium channel activation and podocyte injury in Dahl salt-sensitive rats (2022) (1)
[PS 01-26] THE ROLE OF ACTIVATED RENIN-ANGIOTENSIN SYSTEM FOR THE MRP8/TLR4 SIGNALING IN DIABETIC NEPHROPATHY (2016) (1)
Salt-Sensitive Hypertension of the Renal Tubular Cell–Specific NFAT5 (Nuclear Factor of Activated T-Cells 5) Knockout Mice (2021) (1)
PS-R05-6: A CASE OF ACUTE KIDNEY INJURY WITH THROMBOTIC MICROANGIOPATHY CAUSED BY MALIGNANT HYPERTENSION (2023) (0)
The predictive role of serum calprotectin on mortality in hemodialysis patients with high phosphoremia (2020) (0)
The natriuretic peptide family. (1996) (0)
MP418THE ROLE OF LOCALLY ACTIVATED RENIN-ANGIOTENSIN SYSTEM FOR THE MRP8/TLR4 SIGNALING IN DIABETIC NEPHROPATHY (2016) (0)
[Atrial natriuretic peptides. The function of the atrial natriuretic peptide as hormone and neuropeptide]. (1987) (0)
A4982 Effects of obesity on urinary acid excretion and kidney injury in chronic kidney disease (2018) (0)
AMILORIDE ATTENUATES ALDOSTERONE-INDUCED RENAL INJURIES VIA THE SUPPRESSION OF PLASMIN ACTIVITY IN THE KIDNEY (2021) (0)
Potent depressor action of leumorphin, a kappa-opioid agonist, in conscious rats. (1988) (0)
Diabetes mellitus - basic research (2009) (0)
-153-DISTRIBUTION OF ATRIAL NATRIURETIC POLYPEPTIDE AND ITS RELATIONS WITH FUNCTION AND HISTOLOGY IN DILATED CARDIOMYOPATHY : IMMUNOHISTOCHEMICAL STUDY OF ENDOMYOCARDIAL BIOPSY : Cardiomyopathy : FREE COMMUNICATIONS(I) : PROCEEDINGS OF THE 53th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRCULATION S (1989) (0)
EFFECTS OF NUCLEAR FACTOR OF ACTIVATED T-CELLS 5 (NFAT5) KNOCKOUT IN RENAL TUBULAR CELLS ON RENAL FIBROGENESISNFAT5 (NUCLEAR FACTOR OF ACTIVATED T-CELLS 5) IS A TRANSCRIPTION FACTOR (2021) (0)
Hemodynamic, Renal, andHormonal Responses toBrainNatriuretic Peptide Infusion inPatients With Congestive HeartFailure (1991) (0)
PS-BPB10-5: POSSIBLE INVOLVEMENT OF RENAL TUBULAR NFAT5 IN AGING-ASSOCIATED RENAL DYSFUNCTION AND SALT-SENSITIVE HYPERTENSION (2023) (0)
PS-BPB10-1: INVOLVEMENT OF RENAL TUBULAR NFAT5 IN THE REGULATION OF BLOOD PRESSURE AND BODY FLUID VOLUME (2023) (0)
FP281POST-TRANSLATIONAL MODIFICATION OF MRP8 (S100A8) AND ITS ROLE IN CHRONIC KIDNEY DISEASE (2018) (0)
Role of endogenous opioid peptides in control of vasopressin secretion (1989) (0)
PS-R04-5: A CASE OF SEVERE RENAL FAILURE WITH HYPERTENSIVE EMERGENCY WHO SUCCEEDED IN HEMODIALYSIS WITHDRAWAL BY STRICT CONTROL OF BLOOD PRESSURE (2023) (0)
A monoclonal antibody against N-terminus of alpha-atrial natriuretic polypeptide (alpha-ANP): a useful tool for preferential detection of naturally circulating ANP. (1988) (0)
MPS 01-03 SERINE PROTEASE INHIBITION ATTENUATES SALT-SENSITIVE HYPERTENSION AND PODOCYTE INJURY IN A RAT MODEL OF METABOLIC SYNDROME (2016) (0)
PS-BPB05-3: SERINE PROTEASE INHIBITION EXERTS AQUARETIC EFFECT AND DECREASES URINARY EXOSOMAL AQP2 LEVELS (2023) (0)
The NHLBI Centers Program: The Sun Also Rises (2005) (0)
S-16-6: NATRIURETIC PEPTIDES AND HUMORAL FACTORS IN CARDIORENAL SYNDROME AND RESISTANT HYPERTENSION (2023) (0)
[Nerve tissue distribution and physiologic role of endogenous opioid peptides and their receptors--POMC-, proenkephalin A, proenkephalin B- derived opioid peptides and kyotorphin]. (1990) (0)
SP072THE EFFECTS OF SERINE PROTEASE INHIBITION ON SALT-SENSITIVE HYPERTENSION AND PODOCYTE INJURY IN A RAT MODEL OF METABOLIC SYNDROME (2018) (0)
Lessons from analysis of a single urinary biomarker, Ngal (2011) (0)
BRAIN NATRIURETIC PEPTIDE ACTS LOCALLY AS AN ANTI-FIBROTIC FACTOR: P1.231 (2000) (0)
Clinical significance of ANP and BNP (1992) (0)
Discussion on Management of Metabolic and Endocrine Disorders for General Practitioners (2019) (0)
[A case of malignant lymphoma, highly suspected to be of pancreatic origin, with multiple nodular hepatic invasions]. (1994) (0)
PS 10-06 ALDOSTERONE MODULATES EXPRESSION OF AN ACID-SECRETING AMMONIA TRANSPORTER Rhcg IN INTERCALATED CELLS OF THE COLLECTING DUCTS (2016) (0)
[The elevated level of brain natriuretic peptide (BNP) in the umbilical cord plasma under with fetal distress]. (1992) (0)
Translational medicine of natriuretic peptide family (2002) (0)
PS-BPC11-3: INVESTIGATION OF THE EFFECT OF VISCERAL FAT ON THE CHRONIC KIDNEY DISEASE DEVELOPMENT AND PROGRESSION IN MEDICAL CHECKUP PARTICIPANTS (2023) (0)
[Diuretic and renoprotective effects of natriuretic peptides]. (2004) (0)
Treatment of congestive heart failure with atrial natriuretic polypeptide (1988) (0)
POS-356 Suppression of ER-associated degradation by intraglomerular crosstalk between mesangial cells and podocytes causes podocyte injury in diabetic kidney disease (2021) (0)
Enzyme immunoassay for alpha-human atrial natriuretic polypeptide--direct measurement of plasma level. (1988) (0)
FP002Effects of aldosterone on the expression of Rhcg, an ammonia transporter, in the intercalated cells of the collecting duct under metabolic acidosis (2019) (0)
Gene expression of natriuretic peptide receptor subtypes in the kidney of SHR-stroke prone (1995) (0)
PS 04-04 COMPUTATIONAL ANALYSIS OF THE EFFECTS OF ALDOSTERONE AND METABOLIC ACIDOSIS ON GENE EXPRESSIONS IN RENAL TUBULES (2016) (0)
PS-B08-13: PLASMIN INHIBITION ALLEVIATES HYPERTENSION AND PODOCYTE INJURY IN DAHL SALT-SENSITIVE RATS (2023) (0)
NEW CONCEPT CONCERNING THE MECHANISM OF ALBUMINURIA IN THE EARLY STAGE OF DIABETIC NEPHROPATHY: INCREASED GLOMERULAR FILTRATION WITH PARTIAL COMPENSATION BY INCREASED TUBULAR REABSORPTION: TO049 (2017) (0)
Circulating NGAL accelerates diet-induced obesity through local inhibition of thermogenic beta3 adrenergic nerve/brown adipose tissue axis (2018) (0)
[Early biomarker for AKI]. (2010) (0)
3 New development of Targetting Renal Failure(New Progress in Clinical Application of Natriuretic Peptide Family,Roundtable Discussion 1 (RT1) (H),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society) (2006) (0)
Impaired Guanosine 3 ' , 5 '-Cyclic Phosphate Product Severe Pregnancy-Induced Hypertension with High Levels of Atrial and Brain Natriuretic Peptides ion in Plasma (2006) (0)
Obesity-promoting and anti-thermogenic effects of neutrophil gelatinase-associated lipocalin in mice (2017) (0)
Osteocrin ameliorates adriamycin nephropathy via p38 mitogen-activated protein kinase inhibition (2021) (0)
-421- TISSUE CONCENTRATION AND MOLECULAR FORM OF ATRIAL NATRIURETIC POLYPEPTIDE (ANP) IN HUMAN FAILING HEARTS (1987) (0)
-0497-HYPERTROPHY OF HEART MUSCLE CELLS AND DISTRIBUTION OF ANP IN OLD MYOCARDIAL .INFARCTION AFTER KAWASAKI DISEASE (1990) (0)
-1150-GENE EXPRESSION OF THREE TYPES OF RECEPTORS FOR NATRIURETIC PEPTIDES (ANP・BNP) : THE 54th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRCULATION SOCIETY (1990) (0)
PS-BPB03-5: DEVELOPMENT OF A THERAPEUTIC VACCINE FOR DYSLIPIDEMIA AND RELATED DISEASES TARGETING ANGIOPOIETIN-LIKE PROTEIN 3 (ANGPTL3). (2023) (0)
-0793-SYNTHESIS AND SECRETION OF ENDOTHELIN-1 AND 6K ENDOTHELIN-LIKE PEPTIDE (ELP) IN PORCINE ENDOTHELIAL CELLS (1990) (0)
STAT3 is Activated by CTGF-mediated Tumor-stroma Cross Talk to Promote HCC Progression (2022) (0)
Title Low Serum Neutrophil Gelatinase-associated Lipocalin Level as a Marker of Malnutrition in Maintenance Hemodialysis Patients (2018) (0)
URINARY PLASMIN PLAYS PATHOGENIC ROLES FOR THE DEVELOPMENT OF HYPERTENSION IN SALT-SENSITIVE HYPERTENSION WITH PROTEINURIA (2021) (0)
WCN23-0816 EXPLORATION OF NOVEL EXOSOME-TARGETED STRATEGY FOR DIABETIC KIDNEY DISEASE BY DRUG SCREENING TO INHIBIT INTRAGLOMERULAR CROSS-COMMUNICATION (2023) (0)
-0820-EXPRESSION OF ATRIAL NATRIURETIC POLYPEPTIDE IN THE VENTRICLE OF THE HUMAN HEARTS WITH MYOCARDIAL INFARCTION : THE 54th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRCULATION SOCIETY (1990) (0)
Reduced expression of antihypertensive angiotensin II type 2 (AT2) receptor in the kidney and cultured mesangial cells from stroke-prone SHR. (1997) (0)
Atrial natriuretic polypeptide as a neuropeptide (1988) (0)
A Possible Reno-protective Effect of Systemic Thermal Stimulation in a Mouse Remnant Kidney Model (2015) (0)
Increased numbers of pre-operative circulating monocytes predict risk of developing cardiac surgery-associated acute kidney injury in conditions requiring cardio pulmonary bypass (2022) (0)
Autosomal dominant Alport syndrome due to a COL4A4 mutation with an additional ESPN variant detected by whole-exome analysis (2019) (0)
MPS 07-05 ROLE OF THE NATRIURETIC PEPTIDE-A RECEPTOR ON PODOCYTES IN ALDOSTERONE-INDUCED GLOMERULAR INJURY (2016) (0)
PS 16-06 A SERINE PROTEASE INHIBITOR INCREASES FREE WATER EXCRETION IN NORMAL RATS (2016) (0)
A Case of Marked Hypocalcemia with Mild Renal Dysfunction Diagnosed as Pseudohypoparathyroidism Type 2 (2017) (0)
SP074SERINE PROTEASE INHIBITION ATTENUATES SALT-SENSITIVE HYPERTENSION AND KIDNEY INJURY IN A RAT MODEL OF METABOLIC SYNDROME (2016) (0)
Systemic thermal stimulation ameliorates renal tubular injury in a mouse model of renal ablation (2015) (0)
Possible modulatory roles of natriuretic peptide systems in the progression of renal disorders (1994) (0)
[Syndrome of inappropriate secretion of antidiuretic hormone]. (2006) (0)
[Selective hypoaldosteronism]. (2006) (0)
FP280 THE ROLE OF CYSTATIN C AND CYSTATIN C-BASED GFR MARKERS FOR PREDICTION OF MORTALITY IN ELDERLY PATIENTS WITH CHRONIC KIDNEY DISEASE (2018) (0)
[Molecular biology in regulation of kidney functions: Natriuretic peptide system]. (2006) (0)
Sirtuin 7 Deficiency Ameliorates Cisplatin-induced Acute Kidney Injury Through Regulation of the Inflammatory Response (2018) (0)
[The Cutting-edge of Medicine; Endocrine disorders and renal disease]. (2015) (0)
POS-328 SUPPRESSION OF ER-ASSOCIATED DEGRADATION BY INTRAGLOMERULAR CROSS-COMMUNICATION BETWEEN MESANGIAL CELLS AND PODOCYTES CAUSES PODOCYTE INJURY IN DIABETIC KIDNEY DISEASE (2022) (0)
-436- REGULATORY ROLES OF ATRIAL NATRIURETIC POLYPEPTIDE (ANP) AS A NEUROPEPTIDE AND AS A HORMONE IN CENTRAL CARDIOVASCULAR CONTROL (1987) (0)
An autopsy case of fulminant thrombotic thrombocytopenic purpura with a rapidly fatal course that responded poorly to plasma exchange therapy (2022) (0)
-1061-PLASMA ENDOTHELIN (ET) LEVEL IN PATIENTS WITH CARDIOVASCULAR DISORDERS : THE 54th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRCULATION SOCIETY (1990) (0)
SuO009EFFICACY OF BRACHIAL ARTERY SUPERFICIALIZATION AS AN ALTERNATIVE WAY FOR VASCULAR ACCESS IN PATIENTS WITH MAINTENANCE HEMODIALYSIS (2018) (0)
MO003CRUCIAL ROLE OF MESANGIAL CELL-DERIVED CONNECTIVE TISSUE GROWTH FACTOR IN ANTI-GLOMERULAR BASEMENT MEMBRANE GLOMERULONEPHRITIS (2017) (0)
PS-B08-2: EXOSOME-MEDIATED INTERCELLULAR CROSSTALK BETWEEN MESANGIAL CELLS AND MACROPHAGES PARTICIPATES IN THE PROGRESSION OF DIABETIC KIDNEY DISEASE. (2023) (0)
Role of Leu-morphin, an Opioid Peptide, in the Central Regulation of Fluid Balance and Blood Pressure in Rats (1988) (0)
Evaluating phase-specific role of Wnt signaling for podocyte differentiation in the developing kidney (2016) (0)
[Renal actions and renoprotective role of adrenomedullin]. (2004) (0)
Increased Synthesis and Secretion of Atrial Natriuretic Polypeptide (ANP) in the Left Atrium of Spontaneously Hypertensive Rats (SHR) (1988) (0)
A Novel VCP modulator KUS121 exerts renoprotective effects in ischemia-reperfusion injury with retaining ATP and restoring ERAD-processing capacity. (2022) (0)
WCN23-0810 THE EFFECTS OF SGLT2 INHIBITORS ON RENAL FUNCTION AND SERUM SODIUM CONCENTRATION TRENDES IN PATIENTS WITH TYPE 2 DIABETES (2023) (0)
SUN-297 INTRAGLOMERULAR CROSSTALK BETWEEN MESANGIAL CELLS AND PODOCYTES INHIBITS NORMAL ER-ASSOCIATED DEGRADATION PROCESSES AND INDUCES PODOCYTE INJURY IN DIABETIC KIDNEY DISEASE (2019) (0)
CTGF in kidney fibrosis and glomerulonephritis (2018) (0)
Generation of Conditional KO Mice of CCN2 and Its Function in the Kidney. (2023) (0)
SUN-004 Osteocrin, a bone-originated humoral factor, exerts a renoprotective role in ischemia-reperfusion injury in mice (2020) (0)
SUN-143 MATRIX METALLOPROTEINASE-10 (MMP-10) IS A KEY MOLECULE IN ALDOSTERONE-INDUCED GLOMERULAR INJURY IN SYSTEMIC GUANYLYL CYCLASE-A KNOCKOUT MICE (2019) (0)
Enhanced AT1 receptor-mediated Growth Response of Cultured Mesangial Cells from Stroke-Prone SHR (1998) (0)
Immunohistochemical Study of the Endomyocardial Biopsy Specimens (2005) (0)
AMに固有のモノクローナル抗体により明らかになる、培養メサンギウム細胞におけるアドレノメデュリン(AM)の産生と作用 (1995) (0)
Isolation and characterization of porcine endothelin-like peptide. (1991) (0)
Camostat mesilate, a serine protease inhibitor, exerts aquaretic effects and decreases urinary exosomal AQP2 levels. (2022) (0)
Ablation of Myeloid Cell MRP8 Ameliorates Nephrotoxic Serum-induced Glomerulonephritis by Affecting Macrophage Characterization through Intraglomerular Crosstalk (2020) (0)
[Plasma levels of brain natriuretic peptide (BNP) in the women with severe pregnancy-induced hypertension]. (1992) (0)
-1155-CO-EXISTENCE OF A FAMILY OF NATRIURETIC PEPTIDES, ANP AND BNP, IN RAT HEART : IMMUNOHISTOCHEMICAL STUDY : THE 54th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRCULATION SOCIETY (1990) (0)
[Central core disease and multicore disease]. (1978) (0)
Successful treatment with rituximab and plasmapheresis of renal involvement of eosinophilic granulomatosis with polyangiitis (2023) (0)
Cardiac tamponade caused by uremic pericarditis in a patient with endstage renal disease due to diabetic nephropathy (2007) (0)
S-10-2: OPTIMAL BLOOD PRESSURE TARGET TO PREVENT SEVERE HYPERTENSION IN PREGNANCY: A SYSTEMATIC REVIEW AND META-ANALYSIS (2023) (0)
URINARY AMMONIUM EXCRETION BY ALDOSTERONE THROUGH THE REGULATION OF RH C GLYCOPROTEIN IN THE INTERCALATED CELLS OF THE RENAL COLLECTING DUCT (2021) (0)
[Kidney and hypertension]. (2016) (0)
POS-018 A NOVEL ATP-RETAINING COMPOUND, KUS121, ENHANCES ER-ASSOCIATED DEGRADATION AND EXERTS RENOPROTECTIVE EFFECTS AGAINST ACUTE KIDNEY INJURY (2022) (0)
-0491-HETEROGENEITY AND TISSUE SPECIFICITIES OF RECEPTORS FOR NATRIURETIC PEPTIDES (AND・BNP) (1990) (0)
PS-BPB06-7: NOVEL MOLECULAR MECHANISMS OF CARDIO-RENAL INTERACTION MEDIATED BY INCREASED SERUM MODIFIED NUCLEOSIDES ASSOCIATED WITH RENAL FAILURE (2023) (0)
Successful treatment of metformin-associated lactic acidosis in a hemodialysis patient (2018) (0)
5-8 Recent trends in acute kidney injury biomarkers (2014) (0)
MP006TSS-SEQ ANALYSIS OF LOW PH-INDUCED GENE EXPRESSION IN INTERCALATED CELLS OF THE RENAL COLLECTING DUCT (2017) (0)
SUN-181 HIGH SERUM CALPROTECTIN LEVELS MAY PREDICT MORTALITY RISK IN HEMODIALYSIS PATIENTS WITH HIGH-PHOSPHATE CONDITIONS (2020) (0)
[Evaluation of tubulointerstitial injury by new biomarkers]. (2011) (0)
PS-BPC10-6: RELATIONSHIP BETWEEN CIRCULATING ANGIOPOIETIN-LIKE PROTEIN 2 LEVELS AND ARTERIAL STIFFNESS IN PATIENTS RECEIVING MAINTENANCE HEMODIALYSIS (2023) (0)
EXPERIMENTAL RENAL PATHOLOGY MO001 MAFB IS ESSENTIAL FOR THE MAINTENANCE OF PODOCYTES IN BOTH MICE AND HUMANS KEY IN PATIENTS WITH IMPAIRMENT (2017) (0)
[Clinical implication of a novel biomarker Ngal in CKD]. (2009) (0)
Circulating Neutrophil Gelatinase-Associated Lipocalin Level Is Determined by Nutritional Status and White Blood Cell Count but Not by Iron in Maintenance Hemodialysis Patients (2009) (0)
735 Role of P38 MAPK in aldosterone-induced glomerular injury in natriuretic peptide receptor-A deficient mice (2012) (0)
A case of chyluria with nephrotic-range proteinuria caused by lymphatic malformation, leading to a diagnosis of Klippel–Trenaunay syndrome (2022) (0)
SAT-106 POTENTIAL ROLE OF MRP8 IN GLOMERULAR INJURY THROUGH INTRAGLOMERULAR CROSSTALK AFFECTING MACROPHAGE CHARACTERIZATION (2019) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Masashi Mukoyama?

Masashi Mukoyama is affiliated with the following schools:

Masashi Mukoyama's Academic­Influence.com Rankings